Thursday, January 19, 2017

BRIEF-Allergan announces FDA approval of RHOFADE cream

* Allergan announces FDA approval of RHOFADE (oxymetazoline

hydrochloride) cream, 1% for the topical treatment of persistent

facial Erythema associated with Rosacea in adults

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)